Follow
Jacob A Torres
Title
Cited by
Cited by
Year
Ketosis ameliorates renal cyst growth in polycystic kidney disease
JA Torres, SL Kruger, C Broderick, T Amarlkhagva, S Agrawal, JR Dodam, ...
Cell metabolism 30 (6), 1007-1023. e5, 2019
1912019
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
JA Torres, M Rezaei, C Broderick, L Lin, X Wang, B Hoppe, BD Cowley, ...
The Journal of clinical investigation 129 (10), 4506-4522, 2019
882019
Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease
T Weimbs, JM Shillingford, J Torres, SL Kruger, BC Bourgeois
Clinical Kidney Journal 11 (suppl_1), i27-i38, 2018
512018
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects
S Strubl, S Oehm, JA Torres, F Grundmann, J Haratani, M Decker, ...
Clinical kidney journal 15 (6), 1079-1092, 2022
432022
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—A randomized controlled trial
S Cukoski, CH Lindemann, S Arjune, P Todorova, T Brecht, A Kühn, ...
Cell Reports Medicine 4 (11), 2023
342023
STAT signaling in polycystic kidney disease
S Strubl, JA Torres, AK Spindt, H Pellegrini, MC Liebau, T Weimbs
Cellular signalling 72, 109639, 2020
242020
Ren. Nu, a dietary program for individuals with autosomal-dominant polycystic kidney disease implementing a sustainable, plant-focused, kidney-safe, ketogenic approach with …
DM Bruen, JJ Kingaard, M Munits, CS Paimanta, JA Torres, J Saville, ...
Kidney and Dialysis 2 (2), 183-203, 2022
222022
Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease
EE Olsan, JD West, JA Torres, N Doerr, T Weimbs
American Journal of Physiology-Renal Physiology 315 (1), F86-F96, 2018
202018
A combination of β-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease
JA Torres, N Holznecht, DA Asplund, T Amarlkhagva, BC Kroes, J Rebello, ...
American Journal of Physiology-Renal Physiology 326 (3), F352-F368, 2024
72024
Eosinophilic esophagitis: Report of three cases
FCG González, J Torres, UR Molina, PR Harris
Revista Medica de Chile 137 (5), 666-671, 2009
72009
Kidney homografts: induction of specific tolerance through the lymphoid tissues
J Parra, JA Torres, F Alvarez, R Vela, C Albert, H Oliva
Annals of the New York Academy of Sciences 120 (2), 524-534, 1965
71965
Broderick Cet al
JA Torres, SL Kruger
Ketosis ameliorates renal cyst growth in polycystic kidney disease. Cell …, 2019
52019
Methods and compositions for supporting renal health
T Weimbs, J Torres, M Thangaraju
US Patent 11,013,705, 2021
42021
Pharmacological effects of panduratin a on renal cyst development in in vitro and in vivo models of polycystic kidney disease
K Tonum, N Srimai, N Chabang, S Fongsupa, P Tuchinda, JA Torres, ...
International Journal of Molecular Sciences 23 (8), 4328, 2022
32022
β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease
JA Torres, N Holznecht, DA Asplund, BC Kroes, T Amarlkhagva, ...
Iscience 27 (9), 2024
22024
Time-Restricted Feeding Outperforms Periodic Fasting Head-to-Head in Slowing and Reversing Progression of Polycystic Kidney Disease in the Han: SPRD Rat Model: FR-PO295
JA Torres, NJ Holznecht, DA Asplund, BC Kroes, S Strubl, M Schimmel, ...
Journal of the American Society of Nephrology 33 (11S), 406, 2022
12022
TO035 CALCIUM OXALATE CRYSTALS PROMOTE CYTOGENESIS AND AGGRAVATE POLYCYSTIC KIDNEY DISEASE
M Rezaei, J Torres, L Lin, C Broderick, B Cowley, V Torres, S Khan, ...
Nephrology Dialysis Transplantation 32 (suppl_3), iii94-iii94, 2017
12017
Metabolite Changes while Adhering to a Ketogenic Diet in Autosomal Dominant Polycystic Kidney Disease: TH-PO441
MGE Knol, S Arjune, MDA van Gastel, JA Torres, T Weimbs, RU Mueller, ...
Journal of the American Society of Nephrology 35 (10S), 10.1681, 2024
2024
A Ketogenic Diet Alters Liver Cyst Progression in a Rodent Model of Polycystic Kidney Disease and Is Dependent on GPR109A: TH-PO438
JA Torres, BA Aceves, M Messing, NJ Holznecht, S Krishnan, R Razavi, ...
Journal of the American Society of Nephrology 35 (10S), 10.1681, 2024
2024
Real-Life Data from a Ketogenic Metabolic Therapy Program for Autosomal-Dominant Polycystic Kidney Disease Suggests Significant Benefits to Participants: TH-PO440
EG Muensterman, KL Welsh, D Bruen, JA Torres, T Weimbs, J Saville
Journal of the American Society of Nephrology 35 (10S), 10.1681, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20